Close Menu
Home » NCI-MATCH Sees Lots of Enthusiasm in Initial Months; Not Many Matches

NCI-MATCH Sees Lots of Enthusiasm in Initial Months; Not Many Matches

Jan 22, 2016
|
Turna Ray
Premium

NEW YORK (GenomeWeb) – Enthusiasm for participating in the National Cancer Institute's MATCH trial has been higher than investigators expected, but, according to researchers knowledgeable of the project, the study hasn't yet "matched" many patients to treatments based on the genomic markers driving their disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

So, So Many

According to Gizmodo, researchers have developed a list of a million nucleic acid-like polymers that could store genetic information.

Golden Rice Soon?

An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.

To Share More

US National Institutes of Health has issued a new draft data-sharing policy, ScienceInsider reports.

Cell Studies Assess Hepatocellular Carcinoma Immune Cells, Renal Cell Carcinoma, More

In Cell this week: analysis of immune microenvironment in hepatocellular carcinoma, proteogenomic analysis of clear cell renal cell carcinoma, and more.

Nov
19
Featured Webinar

Digital PCR for Tag Copy Number Assessment in CRISPR-Edited Cell Lines

Sponsored by
Stilla

Fluorescent proteins or self-labeling tags are invaluable tools for studying protein dynamics in living cells using fluorescence microscopy. However, quantitative imaging requires physiological levels of expression of the target protein of interest (POI), especially when stoichiometric interactions of the POI need to be investigated.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
04
Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

What's Popular?

In Molecular Diagnostics

  1. Exact Sciences Sues Johns Hopkins University for 'Improperly' Demanding Royalties

  2. FDA Clears NantHealth Tumor-Normal Whole-Exome Test

  3. AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions

    Premium

  4. Adaptive Biotechnologies Q3 Revenues Rise 52 Percent

  5. Natera Outlines Plans for Cancer, Transplant Assays; Provides Update on Legal Proceedings

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.